ACTL6A and head and neck squamous cell carcinoma: We have discovered that expression of ACTL6A, a gene on the 3q26 amplicon amplified in HNSCC tumors, acts as a switch that suppresses mitochondrial dependency and up-regulates aerobic glycolysis, leading to decreased ROS, cisplatin resistance, and ability to grow in hypoxic environments.